SEARCH

SEARCH BY CITATION

References

  • AGUADO, J.M., PONS, F., CASAFONT, F., SAN MIGUEL, G. & VALLE, R. (1990). Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. J. Clin. Gastroenterol., 12, 550554.
  • ANDERSSON, S.E., JOHANSSON, L.H., LEXMULLER, K. & EKSTROM, G.M. (2000). Anti-arthritic effect of methotrexate: is it really mediated by adenosine? Eur. J. Pharm. Sci., 9, 333343.
  • BLACKBURN, M.R., LEE, C.G., YOUNG, H.W., ZHU, Z., CHUNN, J.L., KANG, M.J., BANERJEE, S.K. & ELIAS, J.A. (2003). Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J. Clin. Invest., 112, 332344.
  • BSHESH, K., ZHAO, B., SPIGHT, D., BIAGGIONI, I., FEOKISTOV, I., DENENBERG, A., WONG, H.R. & SHANLEY, T.P. (2002). The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol., 72, 10271036.
  • BURGESS, L.J., SWANEPOEL, C.G. & TALJAARD, J.J. (2001). The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis. Tuberculosis (Edinb), 81, 243248.
  • CHAN, E.S. & CRONSTEIN, B.N. (2002). Molecular action of methotrexate in inflammatory diseases. Arthritis Res., 4, 266273.
  • CHEN, J.F., HUANG, Z., MA, J., ZHU, J., MORATALLA, R., STANDAERT, D., MOSKOWITZ, M.A., FINK, J.S. & SCHWARZSCHILD, M.A. (1999). A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci., 19, 91929200.
  • CORRAO, G., LEPORE, A.R., TORCHIO, P., VALENTI, M., GALATOLA, G., D'AMICIS, A., ARICO, S. & DI ORIO, F. (1994). The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case–control study. Provincial Group for the Study of Chronic Liver Disease. Eur. J. Epidemiol., 10, 657664.
  • CORRAO, G., ZAMBON, A., BAGNARDI, V., D'AMICIS, A. & KLATSKY, A. (2001). Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol., 11, 458465.
  • CRONSTEIN, B.N., EBERLE, M.A., GRUBER, H.E. & LEVIN, R.I. (1991). Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. U.S.A., 88, 24412445.
  • CRONSTEIN, B.N., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1983a). Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med., 158, 11601177.
  • CRONSTEIN, B.N., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1983b). A new physiological function for adenosine: regulation of superoxide anion production. Trans. Assoc. Am. Physicians, 96, 384391.
  • CRONSTEIN, B.N., LEVIN, R.I., BELANOFF, J., WEISSMANN, G. & HIRSCHHORN, R. (1986). Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest., 78, 760770.
  • CRONSTEIN, B.N., MONTESINOS, M.C. & WEISSMANN, G. (1999). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc. Natl. Acad. Sci. U.S.A., 96, 63776381.
  • CRONSTEIN, B.N., NAIME, D. & OSTAD, E. (1993). The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest., 92, 26752682.
  • CRONSTEIN, B.N., ROSENSTEIN, E.D., KRAMER, S.B., WEISSMANN, G. & HIRSCHHORN, R. (1985). Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J. Immunol., 135, 13661371.
  • DE LA MONTE, S.M., HUTCHINS, G.M. & MOORE, G.W. (1984). Risk factors for development of lethal sequelae after hepatitis B virus infection in humans. Am. J. Med., 77, 482488.
  • DESAI, A., VICTOR-VEGA, C., GADANGI, S., MONTESINOS, M.C., CHU, C.C. & CRONSTEIN, B.N. (2005). Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol., 67, 14061413.
  • DUNWIDDIE, T.V. & MASINO, S.A. (2001). The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 3155.
  • EL YACOUBI, M., LEDENT, C., PARMENTIER, M., COSTENTIN, J. & VAUGEOIS, J.M. (2003). Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology, 45, 977985.
  • EL YACOUBI, M., LEDENT, C., PARMENTIER, M., DAOUST, M., COSTENTIN, J. & VAUGEOIS, J. (2001). Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology, 40, 424432.
  • FERNANDEZ, E., RODRIGO, L., RIESTRA, S., CARCIA, S., GUTIERREZ, F. & OCIO, G. (2000). Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J. Clin. Gastroenterol., 30, 181186.
  • FRENCH, S.W. (2000). Mechanisms of alcoholic liver injury. Can. J. Gastroenterol., 14, 327332.
  • FRIEDMAN, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 22472250.
  • GALLUS, S., TAVANI, A., NEGRI, E. & LA VECCHIA, C. (2002). Does coffee protect against liver cirrhosis? Ann. Epidemiol., 12, 202205.
  • GONZALEZ-BENITEZ, E., GUINZBERG, R., DIAZ-CRUZ, A. & PINA, E. (2002). Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2+ and cAMP. Eur. J. Pharmacol., 437, 105111.
  • HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M. & CHAGOYA DE SANCHEZ, V. (1994). Possible role of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats. Biochim. Biophys. Acta, 1200, 9399.
  • HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M., SUAREZ, J. & CHAGOYA DE SANCHEZ, V. (1990). Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology, 12, 242248.
  • HERNANDEZ-MUNOZ, R., DIAZ-MUNOZ, M., SUAREZ-CUENCA, J.A., TREJO-SOLIS, C., LOPEZ, V., SANCHEZ-SEVILLA, L., YANEZ, L. & DE SANCHEZ, V.C. (2001). Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology, 34, 677687.
  • ISHAK, K., BAPTISTA, A., BIANCHI, L., CALLEA, F., DE GROOTE, J., GUDAT, F., DENK, H., DESMET, V., KORB, G., MACSWEEN, R.N.M., PHILLIPS, M.J., PORTMANN, B.G., POULSEN, H., SCHEUER, P.J., SCHMID, M. & THALER, H. (1995). Histological grading and staging of chronic hepatitis. J. Hepatol., 22, 696699.
  • ITOH, A., NODA, Y., MAMIYA, T., HASEGAWA, T. & NABESHIMA, T. (1998). A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine. Methods Find. Exp. Clin. Pharmacol., 20, 619625.
  • JAMES, J., BOSCH, K.S., ARONSON, D.C. & HOUTKOOPER, J.M. (1990). Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver, 10, 15.
  • KAPLAN, G.B., BHARMAL, N.H., LEITE-MORRIS, K.A. & ADAMS, W.R. (1999). Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol, 19, 157162.
  • KHOA, N.D., MONTESINOS, M.C., REISS, A.B., DELANO, D., AWADALLAH, N. & CRONSTEIN, B.N. (2001). Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J. Immunol., 167, 40264032.
  • KLATSKY, A.L., ARMSTRONG, M.A. & FRIEDMAN, G.D. (1993). Coffee, tea, and mortality. Ann. Epidemiol., 3, 375381.
  • KNODELL, R.G., ISHAK, K.G., BLACK, W.C., CHEN, T.S., CRAIG, R., KAPLOWITZ, N., KIERNAN, T.W. & WOLLMAN, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1, 431435.
  • LEE, H.T., OTA-SETLIK, A., XU, H., D'AGATI, V.D., JACOBSON, M.A. & EMALA, C.W. (2002). A3 adenosine receptor knock-out mice are protected against ischemic- and myoglobinuric-induced renal failure. Am. J. Physiol. Renal Physiol., 284, F267F273.
  • LI, D. & FRIEDMAN, S.L. (1999). Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol., 14, 618633.
  • LINDEN, J. (2001). Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol., 41, 775787.
  • MAUVIEL, A., REDINI, F., HARTMANN, D.J., PUJOL, J.P. & EVANS, C.H. (1991). Modulation of human dermal fibroblast extracellular matrix metabolism by the lymphokine leukoregulin. J. Cell Biol., 113, 14551462.
  • MIYAMOTO, K. & FRENCH, S.W. (1988). Hepatic adenosine in rats fed ethanol: effect of acute hyperoxia or hypoxia. Alcohol Clin. Exp. Res., 12, 512515.
  • MONTESINOS, M.C., DESAI, A., CHEN, J.F., YEE, H., SCHWARZSCHILD, M.A., FINK, J.S. & CRONSTEIN, B.N. (2002). Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am. J. Pathol., 160, 20092018.
  • MONTESINOS, M.C., GADANGI, P., LONGAKER, M., SUNG, J., LEVINE, J., NILSEN, D., REIBMAN, J., LI, M., JIANG, C.K., HIRSCHHORN, R., RECHT, P.A., OSTAD, E., LEVIN, R.I. & CRONSTEIN, B.N. (1997). Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J. Exp. Med., 186, 16151620.
  • MORABITO, L., MONTESINOS, M.C., SCHREIBMAN, D.M., BALTER, L., THOMPSON, L.F., RESTA, R., CARLIN, G., HUIE, M.A. & CRONSTEIN, B.N. (1998). Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest., 101, 295300.
  • MOSER, G.H., SCHRADER, J. & DEUSSEN, A. (1989). Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol., 256, C799C806.
  • NAASSILA, M., LEDENT, C. & DAOUST, M. (2002). Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J. Neurosci., 22, 1048710493.
  • NAGY, L.E., DIAMOND, I., CASSO, D.J., FRANKLIN, C. & GORDON, A.S. (1990). Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J. Biol. Chem., 265, 19461951.
  • NGUYEN, D.K., MONTESINOS, M.C., WILLIAMS, A.J., KELLY, M. & CRONSTEIN, B.N. (2003). Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J. Immunol., 171, 39913998.
  • OHTA, A. & SITKOVSKY, M. (2001). Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature, 414, 916920.
  • PUIG, J.G. & FOX, I.H. (1984). Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J. Clin. Invest., 74, 936941.
  • QUIROZ, S.C., BUCIO, L., SOUZA, V., HERNANDEZ, E., GONZALEZ, E., GOMEZ-QUIROZ, L., KERSHENOBICH, D., VARGAS-VORACKOVA, F. & GUTIERREZ-RUIZ, M.C. (2001). Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. J. Gastroenterol. Hepatol., 16, 12671273.
  • RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413492.
  • REEVES, H.L. & FRIEDMAN, S.L. (2002). Activation of hepatic stellate cells – a key issue in liver fibrosis. Front. Biosci., 7, d808d826.
  • REINEHR, R., FISCHER, R. & HAUSSINGER, D. (2002). Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells. Hepatology, 36, 861873.
  • REINSTEIN, L.J., LICHTMAN, S.N., CURRIN, R.T., WANG, J., THURMAN, R.G. & LEMASTERS, J.J. (1994). Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology, 19, 14451452.
  • RUHL, C.E. & EVERHART, J.E. (2005). Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology, 129, 19281936.
  • SHARP, D.S., EVERHART, J.E. & BENOWITZ, N.L. (1999). Coffee, alcohol, and the liver. Ann. Epidemiol., 9, 391393.
  • STEGEMANN, H. & STALDER, K. (1967). Determination of hydroxyproline. Clin. Chim. Acta, 18, 267273.
  • SUN, C.X., YOUNG, H.W., MOLINA, J.G., VOLMER, J.B., SCHNERMANN, J. & BLACKBURN, M.R. (2005). A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest., 115, 3543.
  • TAIMR, P., HIGUCHI, H., KOCOVA, E., RIPPE, R.A., FRIEDMAN, S. & GORES, G.J. (2003). Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology, 37, 8795.
  • TOBIAS, H. & AUERBACH, R. (1973). Hepatotoxicity of long-term methotrexate therapy for psoriasis. Arch. Intern. Med., 132, 391396.
  • VICTOR-VEGA, C., DESAI, A., MONTESINOS, M.C. & CRONSTEIN, B.N. (2002). Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation, 26, 1924.
  • VOGEL, S., PIANTEDOSI, R., FRANK, J., LALAZAR, A., ROCKEY, D.C., FRIEDMAN, S.L. & BLANER, W.S. (2000). An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res., 41, 882893.
  • WONG, F.W., CHAN, W.Y. & LEE, S.S. (1998). Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol. Appl. Pharmacol., 153, 109118.
  • XU, L., HUI, A.Y., ALBANIS, E., ARTHUR, M.J., O'BYRNE, S.M., BLANER, W.S., MUKHERJEE, P., FRIEDMAN, S.L. & ENG, F.J. (2005). Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut, 54, 142151.